Lifeway Foods Inc - LWAY STOCK NEWS

Lifeway Foods, Inc. announced the launch of its new plant-based Lifeway Oat product line and a Chocolate Kefir flavor at the Natural Products Expo East 2021. Set for release in late-November 2021, Lifeway Oat offers a vegan, USDA Organic option to consumers, featuring 10 live probiotic cultures. The market for oat milk has surged, with sales increasing nearly 1200% in two years. Market research predicts the global probiotic drinks market could reach $23.9 billion by 2028. Lifeway Foods aims to meet growing consumer demand for plant-based nutrition.

Lifeway Foods, Inc. has acquired certain assets of California-based GlenOaks Farms, Inc. for $5.8 million, enhancing its position in the probiotic drinkable yogurt market. The acquisition aligns with Lifeway's strategy to expand its product offerings and regional strength, particularly in the West, where GlenOaks has established distribution channels. This move is expected to be accretive to earnings per share and leverage existing infrastructure to boost cash flow. Lifeway aims to capitalize on the increasing consumer focus on local brands and health-oriented products.

Lifeway Foods reported a strong second quarter in 2021, achieving a 16.6% increase in net sales, totaling $29.2 million, compared to the same period in 2020. This marks the company's seventh consecutive quarter of year-over-year growth, driven primarily by increased sales of branded drinkable kefir. Despite a slight dip in gross profit margin to 26.3% due to rising milk prices, operating expenses declined, positively impacting net income, which rose to $1.6 million or $0.10 per share. Strategic expansions in France and the acquisition of GlenOaks Farms further bolster Lifeway's growth prospects.

Lifeway Foods announced the expansion of its kefir distribution in Ireland, now available at Tesco stores. The initial launch includes 1L Lifeway Kefir bottles, marking a significant step in Lifeway's European strategy. CEO Julie Smolyansky emphasized the importance of this partnership, aiming to reach a wider audience. The demand for kefir drinks surged by 400% last year, with projections showing global kefir sales could hit $2.05 billion by 2025 due to increasing health awareness. Lifeway is recognized as a leading contender in the probiotic market.

Lifeway Foods announces its intent to acquire certain assets of GlenOaks Farms, a California-based drinkable yogurt brand, for $5.8 million. This acquisition aims to strengthen Lifeway's position in the better-for-you drinkable dairy market, particularly in the Western U.S. GlenOaks' products, featuring 3.5 billion probiotic cultures per serving, align closely with Lifeway's health-driven mission. The deal is expected to close in August 2021 and will facilitate distribution expansion and market growth.

Lifeway Foods has launched its mango kefir in Costco France, marking its first entry into the French market. The company, a leader in kefir production, is shipping 250ml bottles aimed at harnessing France's appreciation for fermented dairy. CEO Julie Smolyansky expressed confidence in replicating U.S. success within this new market. The global kefir market is projected to reach $1.23 billion by 2027, underscoring potential growth. Lifeway also established an Instagram presence for marketing in France, enhancing brand visibility.

Lifeway Foods, Inc. (Nasdaq: LWAY) announced a new share repurchase program approved by its Board of Directors, allowing the buyback of up to 250,000 shares in a two-year period. The program will be funded using the company's available cash resources. CEO Julie Smolyansky stated that this initiative reflects the company's confidence in its business and results achieved, which have strengthened its financial reserves. The company aims to return capital to shareholders through this buyback.

Lifeway Foods reported robust Q1 2021 results, achieving a 15.7% increase in net sales to $29.4 million, driven by higher volumes of drinkable kefir and USDA's Food Box program. Net income soared nearly 800%, rising to $1.3 million from $150,000 in Q1 2020. Gross profit margin improved to 27.4% from 23.6% due to operating leverage and favorable milk pricing. Despite a 25.1% increase in selling expenses related to advertising, general and administrative expenses decreased by 8.1%, leading to a promising outlook for 2021.

Lifeway Foods (Nasdaq: LWAY) has highlighted a recent study published in Microbiome that identifies molecules in kefir as potential drug candidates to combat pathogenic bacteria and treat inflammatory conditions, including those caused by COVID-19. The study reveals how a compound secreted by the probiotic yeast K. marxianus modulates bacterial communication and reduces virulence in V. cholerae. Lifeway emphasizes the significance of this research amid the ongoing pandemic, aiming to provide consumers with insights on maintaining health through probiotics.